{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:15:19Z","timestamp":1788988519640,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-024-01580-y","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T08:03:35Z","timestamp":1725005015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancements in research on lactate dehydrogenase A in urinary system tumors"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhiyuan","family":"Zhuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"3","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3322\/caac.21838","volume":"74","author":"N Jokhadze","year":"2024","unstructured":"Jokhadze N, Das A, Dizon DS. Global cancer statistics: a healthy population relies on population health. Cancer J Clin. 2024;74(3):224\u20136.","journal-title":"Cancer J Clin"},{"key":"1580_CR3","first-page":"405","volume-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","author":"K Xu","year":"2021","unstructured":"Xu K, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Volume 371. New York, N.Y.: Science; 2021. pp. 405\u201310. 6527."},{"issue":"1","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1002\/ctm2.279","volume":"11","author":"X-H Wang","year":"2021","unstructured":"Wang X-H, et al. Hypoxia-induced FOXO4\/LDHA axis modulates gastric cancer cell glycolysis and progression. Clin Translational Med. 2021;11(1):e279.","journal-title":"Clin Translational Med"},{"issue":"8","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.7150\/thno.53347","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, et al. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma. Theranostics. 2021;11(8):3868\u201381.","journal-title":"Theranostics"},{"issue":"3632","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.145.3632.595","volume":"145","author":"AP Kraus","year":"1964","unstructured":"Kraus AP, Neely CL. HUMAN ERYTHROCYTE LACTATE DEHYDROGENASE: 4 GENETICALLY DETERMINED VARIANTS. Sci (New York N Y). 1964;145(3632):595\u20137.","journal-title":"Sci (New York N Y)"},{"key":"1580_CR7","first-page":"701","volume-title":"Lactate dehydrogenase electrophoretic variant in a New Guinea Highland population","author":"NM Blake","year":"1969","unstructured":"Blake NM, et al. Lactate dehydrogenase electrophoretic variant in a New Guinea Highland population. Volume 163. New York, N.Y.): Science; 1969. pp. 701\u20132. 3868."},{"issue":"13","key":"1580_CR8","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1073\/pnas.94.13.6658","volume":"94","author":"H Shim","year":"1997","unstructured":"Shim H, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA. 1997;94(13):6658\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1212\/WNL.43.7.1414","volume":"43","author":"H Miyajima","year":"1993","unstructured":"Miyajima H, et al. Molecular characterization of gene expression in human lactate dehydrogenase-A deficiency. Neurology. 1993;43(7):1414\u20139.","journal-title":"Neurology"},{"issue":"6","key":"1580_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9(6):425\u201334.","journal-title":"Cancer Cell"},{"issue":"2","key":"1580_CR11","first-page":"283","volume":"40","author":"MJ Siciliano","year":"1980","unstructured":"Siciliano MJ, et al. A human trophoblastic isozyme (lactate dehydrogenase-Z) associated with choriocarcinoma. Cancer Res. 1980;40(2):283\u20137.","journal-title":"Cancer Res"},{"issue":"21","key":"1580_CR12","first-page":"6178","volume":"60","author":"BC Lewis","year":"2000","unstructured":"Lewis BC, et al. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Res. 2000;60(21):6178\u201383.","journal-title":"Cancer Res"},{"issue":"10","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1007\/s13277-015-3540-x","volume":"36","author":"Z-Y Xian","year":"2015","unstructured":"Xian Z-Y, et al. Inhibition of LDHA suppresses tumor progression in prostate cancer. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2015;36(10):8093\u2013100.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.omto.2020.07.006","volume":"18","author":"MM Mane","year":"2020","unstructured":"Mane MM, et al. Lactate dehydrogenase A depletion alters MyC-CaP tumor metabolism, microenvironment, and CAR T cell therapy. Mol Therapy Oncolytics. 2020;18:382\u201395.","journal-title":"Mol Therapy Oncolytics"},{"issue":"5","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.euf.2018.04.006","volume":"5","author":"K Hiew","year":"2019","unstructured":"Hiew K, et al. Primary mutational landscape linked with pre-docetaxel lactate dehydrogenase levels predicts docetaxel response in metastatic castrate-resistant prostate cancer. Eur Urol Focus. 2019;5(5):831\u201341.","journal-title":"Eur Urol Focus"},{"issue":"2","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.18632\/oncotarget.1529","volume":"5","author":"NMA White","year":"2014","unstructured":"White NMA, et al. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget. 2014;5(2):506\u201318.","journal-title":"Oncotarget"},{"key":"1580_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/prca.201700066","volume":"11","author":"Y Song","year":"2017","unstructured":"Song Y, et al. Data-independent acquisition-based quantitative proteomic analysis reveals potential biomarkers of kidney cancer. Proteomics Clin Appl. 2017;11:11\u20132.","journal-title":"Proteomics Clin Appl"},{"issue":"1","key":"1580_CR18","first-page":"866","volume":"16","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma. Oncol Lett. 2018;16(1):866\u201374.","journal-title":"Oncol Lett"},{"key":"1580_CR19","doi-asserted-by":"publisher","first-page":"e15749","DOI":"10.7717\/peerj.15749","volume":"11","author":"J Chen","year":"2023","unstructured":"Chen J, et al. The novel role of LDHA\/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma. PeerJ. 2023;11:e15749.","journal-title":"PeerJ"},{"key":"1580_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1476-4598-13-101","volume":"13","author":"H Girgis","year":"2014","unstructured":"Girgis H, et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13:101.","journal-title":"Mol Cancer"},{"issue":"1","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/ijo.2015.3014","volume":"47","author":"A Soltysova","year":"2015","unstructured":"Soltysova A, et al. Deregulation of energetic metabolism in the clear cell renal cell carcinoma: a multiple pathway analysis based on microarray profiling. Int J Oncol. 2015;47(1):287\u201395.","journal-title":"Int J Oncol"},{"issue":"9","key":"1580_CR22","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.25543","volume":"128","author":"K Singer","year":"2011","unstructured":"Singer K, et al. Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor. Int J Cancer. 2011;128(9):2085\u201395.","journal-title":"Int J Cancer"},{"issue":"1","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s40001-023-01449-0","volume":"28","author":"H-F Wu","year":"2023","unstructured":"Wu H-F, et al. CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma. Eur J Med Res. 2023;28(1):481.","journal-title":"Eur J Med Res"},{"key":"1580_CR24","doi-asserted-by":"crossref","unstructured":"Cascardo F et al. HO-1 modulates aerobic glycolysis through LDH in prostate cancer cells. Antioxidants (Basel, Switzerland). 2021;10(6).","DOI":"10.3390\/antiox10060966"},{"issue":"12","key":"1580_CR25","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/carcin\/bgz155","volume":"40","author":"KB Singh","year":"2019","unstructured":"Singh KB, et al. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. Carcinogenesis. 2019;40(12):1545\u201356.","journal-title":"Carcinogenesis"},{"issue":"5","key":"1580_CR26","first-page":"2844","volume":"41","author":"H Cheng","year":"2019","unstructured":"Cheng H, et al. PLC\u03b5 promotes urinary bladder cancer cells proliferation through STAT3\/LDHA pathway\u2013mediated glycolysis. Oncol Rep. 2019;41(5):2844\u201354.","journal-title":"Oncol Rep"},{"issue":"11","key":"1580_CR27","first-page":"6838","volume":"11","author":"Y Wei","year":"2019","unstructured":"Wei Y, et al. Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA. Am J Translational Res. 2019;11(11):6838\u201349.","journal-title":"Am J Translational Res"},{"issue":"1","key":"1580_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12935-021-02303-1","volume":"21","author":"T Li","year":"2021","unstructured":"Li T, et al. Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming. Cancer Cell Int. 2021;21(1):597.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"1580_CR29","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1111\/cas.15047","volume":"112","author":"JE Burns","year":"2021","unstructured":"Burns JE, et al. The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets. Cancer Sci. 2021;112(9):3822\u201334.","journal-title":"Cancer Sci"},{"key":"1580_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OTT.S191321","volume":"12","author":"Z Wang","year":"2019","unstructured":"Wang Z, et al. Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer. OncoTargets Therapy. 2019;12:1423\u201332.","journal-title":"OncoTargets Therapy"},{"key":"1580_CR31","doi-asserted-by":"publisher","first-page":"e14591","DOI":"10.7717\/peerj.14591","volume":"11","author":"B Yuan","year":"2023","unstructured":"Yuan B, Zhou J. N6-methyladenosine (m6A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis. PeerJ. 2023;11:e14591.","journal-title":"PeerJ"},{"issue":"5","key":"1580_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41419-022-04863-0","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, et al. Circular RNA circVAMP3 promotes aerobic glycolysis and proliferation by regulating LDHA in renal cell carcinoma. Cell Death Dis. 2022;13(5):443.","journal-title":"Cell Death Dis"},{"issue":"14","key":"1580_CR33","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1111\/jcmm.17418","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, et al. PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells. J Cell Mol Med. 2022;26(14):3837\u201349.","journal-title":"J Cell Mol Med"},{"issue":"22","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"9153","DOI":"10.1158\/0008-5472.CAN-10-1949","volume":"70","author":"H Ashrafian","year":"2010","unstructured":"Ashrafian H, et al. Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis. Cancer Res. 2010;70(22):9153\u201365.","journal-title":"Cancer Res"},{"issue":"45","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"74269","DOI":"10.18632\/oncotarget.12368","volume":"7","author":"J Hao","year":"2016","unstructured":"Hao J, et al. Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy. Oncotarget. 2016;7(45):74269\u201385.","journal-title":"Oncotarget"},{"issue":"5","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","volume":"82","author":"X Jiang","year":"2022","unstructured":"Jiang X, et al. EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling. Cancer Res. 2022;82(5):831\u201345.","journal-title":"Cancer Res"},{"issue":"3","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.7150\/jca.86283","volume":"15","author":"C Cakici","year":"2024","unstructured":"Cakici C, et al. LDH-A inhibitor as a remedy to potentiate the anticancer effect of docetaxel in prostate cancer. J Cancer. 2024;15(3):590\u2013602.","journal-title":"J Cancer"},{"key":"1580_CR38","first-page":"p9516774","volume":"2022","author":"Y-Y Wang","year":"2022","unstructured":"Wang Y-Y, Chen C. lncRNA-DANCR promotes taxol resistance of prostate cancer cells through modulating the miR-33b-5p-LDHA Axis. Dis Markers. 2022;2022:p9516774.","journal-title":"Dis Markers"},{"issue":"6","key":"1580_CR39","doi-asserted-by":"publisher","first-page":"8367","DOI":"10.1007\/s13277-015-4703-5","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu X, et al. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2016;37(6):8367\u201374.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"1580_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/OTT.S358008","volume":"15","author":"M Li","year":"2022","unstructured":"Li M, et al. CDKN3 overcomes bladder cancer cisplatin resistance via LDHA-dependent glycolysis reprogramming. OncoTargets Therapy. 2022;15:299\u2013311.","journal-title":"OncoTargets Therapy"},{"issue":"8","key":"1580_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/mc.23201","volume":"59","author":"G Chen","year":"2020","unstructured":"Chen G, et al. ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer. Mol Carcinog. 2020;59(8):897\u2013907.","journal-title":"Mol Carcinog"},{"issue":"3","key":"1580_CR42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4149\/neo_2022_211021N1497","volume":"69","author":"K-G Xia","year":"2022","unstructured":"Xia K-G, et al. LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer. Neoplasma. 2022;69(3):594\u2013602.","journal-title":"Neoplasma"},{"key":"1580_CR43","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.2147\/OTT.S258724","volume":"13","author":"T Liang","year":"2020","unstructured":"Liang T, et al. FAM46B promotes apoptosis and inhibits glycolysis of prostate cancer through inhibition of the MYC-LDHA axis. OncoTargets Therapy. 2020;13:8771\u201382.","journal-title":"OncoTargets Therapy"},{"issue":"3","key":"1580_CR44","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1002\/ctm2.764","volume":"12","author":"C-Y Lin","year":"2022","unstructured":"Lin C-Y, et al. Inhibition of KDM4C\/c-Myc\/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism. Clin Translational Med. 2022;12(3):e764.","journal-title":"Clin Translational Med"},{"issue":"1","key":"1580_CR45","first-page":"177","volume":"21","author":"OK Kwon","year":"2023","unstructured":"Kwon OK, et al. LDHA desuccinylase sirtuin 5 as a novel cancer metastatic stimulator in aggressive prostate cancer. Proteom Bioinf. 2023;21(1):177\u201389. Genomics.","journal-title":"Proteom Bioinf"},{"issue":"16","key":"1580_CR46","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.7150\/thno.58729","volume":"11","author":"M-J Wu","year":"2021","unstructured":"Wu M-J, et al. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Theranostics. 2021;11(16):7779\u201396.","journal-title":"Theranostics"},{"issue":"1","key":"1580_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/ERC-18-0196","volume":"26","author":"L Xu","year":"2019","unstructured":"Xu L, et al. ATM deficiency promotes progression of CRPC by enhancing Warburg effect. Endocrine-related Cancer. 2019;26(1):59\u201371.","journal-title":"Endocrine-related Cancer"},{"key":"1580_CR48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3389\/fonc.2019.01242","volume":"9","author":"J Guo","year":"2019","unstructured":"Guo J, et al. MiR-204-3p inhibited the proliferation of bladder cancer cells via modulating lactate dehydrogenase-mediated glycolysis. Front Oncol. 2019;9:1242.","journal-title":"Front Oncol"},{"issue":"40","key":"1580_CR49","doi-asserted-by":"publisher","first-page":"67663","DOI":"10.18632\/oncotarget.18801","volume":"8","author":"D Yuan","year":"2017","unstructured":"Yuan D, et al. MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A. Oncotarget. 2017;8(40):67663\u20139.","journal-title":"Oncotarget"},{"issue":"2","key":"1580_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000445125","volume":"99","author":"X Wang","year":"2017","unstructured":"Wang X, et al. Inhibition of LDHA deliver potential anticancer performance in renal cell carcinoma. Urol Int. 2017;99(2):237\u201344.","journal-title":"Urol Int"},{"issue":"1","key":"1580_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41419-024-06450-x","volume":"15","author":"R Liu","year":"2024","unstructured":"Liu R, et al. FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2\u03b1 blockade by facilitating LDHA phosphorylation. Cell Death Dis. 2024;15(1):64.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1580_CR52","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.3892\/mmr.2017.7637","volume":"16","author":"J Zhao","year":"2017","unstructured":"Zhao J, et al. LDHA promotes tumor metastasis by facilitating epithelial\u2013mesenchymal transition in renal cell carcinoma. Mol Med Rep. 2017;16(6):8335\u201344.","journal-title":"Mol Med Rep"},{"key":"1580_CR53","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2147\/OTT.S241717","volume":"13","author":"L Shi","year":"2020","unstructured":"Shi L, et al. PCK1 regulates glycolysis and tumor progression in clear cell renal cell carcinoma through LDHA. OncoTargets Therapy. 2020;13:2613\u201327.","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"1580_CR54","first-page":"224","volume":"42","author":"H Muramatsu","year":"2019","unstructured":"Muramatsu H, et al. Targeting lactate dehydrogenase\u2013A promotes docetaxel\u2013induced cytotoxicity predominantly in castration\u2013resistant prostate cancer cells. Oncol Rep. 2019;42(1):224\u201330.","journal-title":"Oncol Rep"},{"issue":"4","key":"1580_CR55","first-page":"1479","volume":"36","author":"MA Lea","year":"2016","unstructured":"Lea MA, Guzman Y, Desbordes C. Inhibition of growth by combined treatment with inhibitors of lactate dehydrogenase and either phenformin or inhibitors of 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 3. Anticancer Res. 2016;36(4):1479\u201388.","journal-title":"Anticancer Res"},{"issue":"1","key":"1580_CR56","doi-asserted-by":"publisher","first-page":"18409","DOI":"10.1038\/s41598-019-55003-2","volume":"9","author":"C Sourbier","year":"2019","unstructured":"Sourbier C, et al. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc. Sci Rep. 2019;9(1):18409.","journal-title":"Sci Rep"},{"issue":"1","key":"1580_CR57","first-page":"110","volume":"36","author":"M Klagsbrun","year":"1976","unstructured":"Klagsbrun M, Knighton D, Folkman J. Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res. 1976;36(1):110\u20134.","journal-title":"Cancer Res"},{"issue":"1","key":"1580_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12885-018-4442-2","volume":"18","author":"M Martini","year":"2018","unstructured":"Martini M, et al. VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. BMC Cancer. 2018;18(1):553.","journal-title":"BMC Cancer"},{"issue":"2","key":"1580_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jclinpath-2020-206633","volume":"74","author":"F Pierconti","year":"2021","unstructured":"Pierconti F, et al. Methylation study of the Paris system for reporting urinary (TPS) categories. J Clin Pathol. 2021;74(2):102\u20135.","journal-title":"J Clin Pathol"},{"issue":"11","key":"1580_CR60","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.21037\/tau-23-341","volume":"12","author":"B Zhu","year":"2023","unstructured":"Zhu B, et al. Construction of the prognostic model in non-metastatic renal cancer patients with venous tumor thrombus. Translational Androl Urol. 2023;12(11):1645\u201357.","journal-title":"Translational Androl Urol"},{"issue":"3","key":"1580_CR61","first-page":"415","volume":"31","author":"P Pepe","year":"2017","unstructured":"Pepe P, et al. Multiparametric MRI apparent diffusion coefficient (ADC) accuracy in diagnosing clinically significant prostate cancer. In vivo (Athens Greece). 2017;31(3):415\u20138.","journal-title":"In vivo (Athens Greece)"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01580-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01580-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01580-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T09:03:22Z","timestamp":1725008602000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01580-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01580-y","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"12 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}